A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
Clinical trial NCT07771140 · RECRUITING
Trial details
- NCT number
- NCT07771140
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-02
- Primary completion
- 2027-04-11
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.